Press release
Beta-Glucans Market Set to Soar to USD 2.5 Billion by 2035 Amid Surging Demand for Immune-Boosting Ingredients
The global beta-glucans market is on a robust growth trajectory, projected to reach an impressive USD 2.5 billion by 2035, climbing from USD 1.4 billion in 2025. This significant expansion is driven by a compelling 5.5% Compound Annual Growth Rate (CAGR) over the forecast period, fueled by escalating consumer interest in functional, immune-stimulating, and plant-based ingredients across various industries.Access the Complete Report - Drive Your Strategy Forward: https://www.futuremarketinsights.com/reports/beta-glucans-market
The industry's strong momentum reflects a global shift towards preventive health and wellness, with beta-glucans emerging as a key component in dietary supplements, functional foods, and even dermatology products. Consumers are increasingly aware of the immune-modulating, cholesterol-lowering, and overall health-enhancing properties of these versatile compounds. This heightened demand is prompting leading manufacturers, including Kerry Group, DSM, and Tate & Lyle, to strategically increase production capacity and invest in advanced process technologies to enhance yield, purity, and product quality. Their efforts extend to establishing manufacturing units in high-growth regions, optimizing supply chains, and securing raw material supplies, thereby reducing logistics costs and broadening market reach.
Segment-wise, yeast-derived beta-glucans, produced by brands like Biothera, Kemin, and Lesaffre, are witnessing substantial uptake, particularly for gut health, immune support, and cardiovascular benefits, as well as in the burgeoning pet nutrition sector. Simultaneously, soluble beta-glucan remains highly recognized for its proven cholesterol-lowering capabilities, forming a gel-like compound in the digestive system that aids in the excretion of "bad" LDL cholesterol. This scientific validation underpins its widespread incorporation into heart-health-focused food products and dietary supplements. The dietary supplements industry currently leads in application, bolstered by e-commerce expansion and growing consumer awareness around preventive health and chronic disease management.
The competitive landscape is characterized by dominant players like Cargill Inc. (20-25% market share), Koninklijke DSM N.V. (15-20%), and Kerry Group Plc. (10-15%), alongside Tate & Lyle Plc. (8-12%) and Biotec BetaGlucans AS (5-8%). These industry leaders are focusing on high-purity formulations for nutrition, pharmaceuticals, and personal care, employing strategic acquisitions, partnerships, and intensive R&D to diversify their offerings and adapt to evolving regulatory standards. Emerging innovators are contributing with bioactive ingredient solutions and clean-label endorsements. A significant competitive differentiator is sustainability, with an increasing preference for eco-friendly extraction methods, traceable supply chains, and non-GMO sourced ingredients.
Geographically, the market is experiencing robust growth across key regions. China is projected to lead with an impressive 9.5% CAGR from 2025 to 2035, driven by increasing disposable incomes and a strong cultural affinity for mushroom-derived products in traditional medicine. Germany (8.0% CAGR) benefits from a mature natural foods industry and government support for research, while the USA (7.8% CAGR) sees growth from rising consumer awareness and technological advancements in extraction. The UK (7.5% CAGR) and Japan (7.2% CAGR) also demonstrate strong expansion, fueled by demand for clean-label products and sophisticated functional food sectors, respectively.
While the outlook is overwhelmingly positive, the beta-glucans market faces potential risks including supply chain challenges, regulatory compliance complexities, price volatility, and technological limitations. Raw material availability, influenced by environmental factors and global disturbances, remains a crucial concern. However, continuous innovation in extraction technologies, diversified sourcing strategies, and a strong emphasis on scientific validation and regulatory approvals are expected to fortify the industry against these challenges, ensuring sustained growth and broader acceptance of beta-glucans as a preponderant functional ingredient in the global health and wellness landscape.
Stay Informed - Request a Sample Copy for Exclusive Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-489
Browse Related Reports from Food and Beverage Industry:
Beta-Glucanase Market: https://www.futuremarketinsights.com/reports/beta-glucanase-market
Oat Beta-Glucan Market: https://www.futuremarketinsights.com/reports/oat-beta-glucan-market
Yeast Beta Glucan Market: https://www.futuremarketinsights.com/reports/yeast-beta-glucan-market
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
Website: https://www.futuremarketinsights.com
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Beta-Glucans Market Set to Soar to USD 2.5 Billion by 2035 Amid Surging Demand for Immune-Boosting Ingredients here
News-ID: 4120217 • Views: …
More Releases from Future Market Insights

Extruded Snacks Market to Reach USD 170.3 Billion by 2035 Amid Health and Conven …
A new market analysis released today projects the global extruded snacks market to surge from an estimated USD 89.9 billion in 2025 to USD 170.3 billion by 2035, demonstrating a robust Compound Annual Growth Rate (CAGR) of 6.6%. The market is set to deliver an impressive absolute dollar opportunity of USD 80.4 billion over the forecast period, driven by a global consumer shift towards convenient, shelf-stable, and healthier snack options.
The…

Global Banana Flakes Market Soars to USD 876.1 million by 2035, Driven by Health …
A new market analysis reveals the global banana flakes market is set to expand significantly, projecting a robust Compound Annual Growth Rate (CAGR) of 4.6% from 2025 to 2035. The market, valued at USD 559.6 million in 2025, is forecast to reach USD 876.1 million by 2035, fueled by a rising consumer preference for natural, gluten-free, and plant-based ingredients in daily food choices.
This press release offers a detailed look into…

Confectionery Fillings Market Sweetens Global Outlook, Projected to Reach USD 2. …
The global confectionery fillings market is poised for significant growth, with a new market analysis revealing a robust expansion fueled by a surge in consumer demand for innovative flavors and indulgent textures. According to the analysis, the market is estimated at USD 1381.2 million in 2025 and is projected to reach USD 2207.4 million by 2035, exhibiting a healthy compound annual growth rate (CAGR) of 4.8% during the forecast period.
The…

Water Softener Market to Skyrocket to USD 8.7 Billion by 2035, Driven by Smart T …
A new market analysis reveals the global water softener market is poised for significant expansion, with a forecasted value of USD 8.7 billion by 2035. The report, covering the period from 2025 to 2035, projects a robust Compound Annual Growth Rate (CAGR) of 8.3%, up from an estimated USD 3.9 billion valuation in 2025. This surge is fueled by a combination of factors, including increasing consumer awareness of hard water's…
More Releases for Beta
Beta-lactam and Beta-lactamase Inhibitors Market Emerging Trends and Growth Pros …
The global beta-lactam and beta-lactamase inhibitors market is valued at approximately $60 billion in 2024, driven by the rising prevalence of bacterial infections and the increasing resistance to traditional antibiotics. The market is projected to reach around $85 billion by 2034, reflecting a robust growth trajectory. This results in a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period of 2025-2034.
Exactitude Consultancy., Ltd. released a research report…
Beta-Lactams & Beta-Lactamase Inhibitors: A Persistent Powerhouse in the Antibio …
The antibiotics market, despite facing challenges, remains a critical sector in global healthcare. Within this landscape, the Beta-Lactam and Beta-Lactamase Inhibitor segment stands out as a high-opportunity area, driven by the continued prevalence of bacterial infections and the ongoing fight against antimicrobial resistance (AMR).
Market Dynamics and Growth Drivers
Beta-lactam antibiotics, including penicillins and cephalosporins, have been the cornerstone of antibacterial therapy for decades. Their broad spectrum of activity and generally favorable…
apuem - beta
Today the beta phase of apuem starts. Our goal is to create the largest web app collection, and for that we need your help. So if you know a useful online tool that you like to use, suggest it to us. See more: apuem.com/suggestions We appreciate any kind of participation. Thank you very much!
Apuem
Finkenhofstraße 27
60322 Frankfurt am Main
Germany
Jacob Kearson
support@apuem.com
More Information: apuem.com/contact
We and our community search for the best web apps…
Beta-lactam and Beta-lactamase Inhibitors Market to Reach $34,170 Million by 202 …
Global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. The cephalosporin segment accounted more than two-fifths of the total beta-lactam and beta-lactamase inhibitors market share in 2018.
Download Report Sample PDF @ https://www.alliedmarketresearch.com/request-sample/5427
Beta-lactam and beta-lactamase inhibitors are chemical compounds of natural or semi-synthetic or synthetic origin. They inhibit…
Beta-lactam and Beta-lactamase Inhibitors Market Outlook from 2019 to 2028
"According to a new report published titled, ""India Heat Exchangers Market by Type, Material of Construction, and End-User Industry: Opportunity Analysis and Industry Forecast, 2019-2026,"" the India heat exchangers market accounted for revenue of $454.4 million in 2018, and is anticipated to generate $890.0 million by 2026. The market is projected to grow at a CAGR of 8.6% from 2019 to 2026.
Heat exchangers are devices that transfer energy between fluids…
Beta-lactam and Beta-lactamase Inhibitors Market Size, Share, Development by 202 …
Global Info Research offers a latest published report on Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Beta-lactam and Beta-lactamase Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Beta-lactam and Beta-lactamase…